Clinical trials
AMI clinical trials
Below are recruiting ami clinical trials, each written for real people, not researchers. We’re tracking 45 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07400458Recruiting
Long-term study after Hearticellgram-AMI for heart attack patients
This study checks on people who have already received a treatment called Hearticellgram-AMI for heart attack. It wants to see how they are doing over the long term.
Seoul, GangnamAges Any age - NCT07042321Recruiting
Risk factors for blocked heart vessels after emergency angioplasty
This study looks at why some people develop micro-blockages in the heart's small blood vessels after emergency angioplasty (PCI) for a heart attack. If you join, you'll help doctors understand these risks and maybe prevent future problems.
Changsha, Hunan Province,ChinaAges 18 years+ - NCT06009874Recruiting
SGLT2 inhibitor early after heart attack to protect the heart
This study tests whether giving an SGLT2 inhibitor (a diabetes medicine that may also protect the heart) early after a heart attack can help shield the heart from damage. It is for people having a first-time STEMI heart attack who have adequate kidney function and stable blood pressure.
Shibīn al Kawm, MenofiaAges 18–80 - NCT07842770Recruiting
Magnetic brain stimulation to calm stress after heart attack
This trial tests whether magnetic brain stimulation (called TMS) can help calm the overactive stress response and reduce inflammation after a heart attack. If you've recently had a heart attack and your heart rate is fast, this treatment might aid your recovery.
Beijing, Beijing MunicipalityAges 30–75 - NCT07833995Recruiting
Long-term outcomes after heart attack and stenting
This study looks at what happens to people after they have a heart attack and receive a stent (a small mesh tube) to open the blocked heart artery. It will track their health over time to better understand the short- and long-term risks of heart and brain events like another heart attack or stroke, so doctors can improve care.
ShanghaiAges 18 years+ - NCT07820072Recruiting
Temporary pacemaker safety and performance study
This study tests a temporary pacing wire that helps control heart rhythm during procedures or when the heart beats too slowly. It aims to see if the device works well and is safe for people who need short-term pacing.
Acquaviva delle Fonti, BariAges 18 years+ - NCT07792694Recruiting
Predicting dangerous heart rhythms with smart software
This study uses computer software to analyze heart rhythm recordings from patients in the hospital to predict dangerous irregular heartbeats (arrhythmias). It aims to improve early detection and care for patients with heart conditions.
Eindhoven, North BrabantAges 18 years+ - NCT07684924Recruiting
Early FAPI PET/MRI after a heart attack
This study uses a new type of PET/MR scan (FAPI) to look at inflammation in the heart shortly after a heart attack. It may help doctors understand recovery better and guide future treatments.
AnkaraAges 18–90 - NCT07687576RecruitingPhase 2/Phase 3
Comparing clot removal methods for heart attack patients
This trial tests if a special device that sucks out blood clots during a heart attack is better than standard care for reducing clot size before placing a stent. It may help patients who have a large clot and a blocked artery.
Oxford, OxfordshireAges 18 years+ - NCT07620119Recruiting
AI-assisted heart attack diagnosis in patients with LBBB
This study tests whether artificial intelligence can help doctors more accurately diagnose heart attacks in patients who have a specific heart rhythm pattern called Left Bundle Branch Block (LBBB). The goal is to improve emergency care by reducing delays in identifying who needs urgent treatment.
Konya, KaratayAges 18 years+ - NCT06212921Recruiting
Biomarkers to predict acute mesenteric ischemia
This trial is looking for biomarkers (clues in your blood) that can help doctors predict acute mesenteric ischemia, a condition where blood flow to your gut is suddenly blocked. It may help find better ways to diagnose this serious condition early.
TartuAges 18 years+ - NCT07583784Recruiting
Shorter blood thinner treatment after heart attack with irregular heartbeat
This trial tests whether patients with both irregular heartbeat (atrial fibrillation) and a recent heart attack can safely take a shorter course of blood-thinning medications after a stent procedure. The goal is to reduce bleeding risk while still protecting against future clots.
Gwangju, GwangjuAges 19 years+ - NCT07567625Recruiting
Heart Attack Treatment Without a Stent
This trial tests whether patients who have had a heart attack with a specific type of artery blockage can be safely treated without placing a metal stent (tube) in their artery. Doctors will monitor whether the blockage stays open on its own.
Harbin, HeilongjiangAges 18–75 - NCT06745141Recruiting
Gum disease treatment after a heart attack
This trial tests whether treating severe gum disease can improve recovery after a heart attack (STEMI). If you recently had a heart attack and also have serious gum problems, you may be able to join and receive periodontal care.
Shanghai, Shanghai MunicipalityAges 30 years+ - NCT07537296Recruiting
Heart Imaging Study After Heart Attack
This study uses advanced CT scans to take detailed pictures of your heart and blood vessels after a recent heart attack treated with stent placement. The goal is to better understand heart damage and predict long-term outcomes.
Nanjing, JiangsuAges 18 years+ - NCT07537868RecruitingPhase 2
Montelukast to reduce heart damage after heart attack
This study tests whether montelukast (a medication that reduces inflammation) can limit heart damage when given immediately after a sudden heart attack. Researchers will measure inflammation markers and heart injury to see if this drug helps patients recover better.
Al MansurahAges 30–75 - NCT07517523Recruiting
Heart Rhythm Problems During Heart Attack
This study looks at dangerous heart rhythms that happen during a heart attack. Researchers will review medical records from 2012–2024 to understand these rhythms better and potentially improve treatment.
CaenAges 18 years+ - NCT07467213RecruitingPhase 3
Acid reflux drug for heart attack recovery
This trial tests if a newer acid-reducing drug is better than standard care for preventing stomach problems in people who recently had a heart attack and a stent placed. It could help those who need stomach protection while on blood thinners.
SeoulAges 19 years+ - NCT06101862Recruiting
CT scan vs. angiogram for certain heart attacks
This trial compares two ways to look at heart arteries: a CT scan (noninvasive) versus a traditional angiogram (a tube put into an artery). The goal is to see which is better for people having a certain type of heart attack.
Copenhagen, HellerupAges Any age - NCT07362446RecruitingPhase 2
Study of a heart drug for first-time heart attack patients
This trial tests a new drug given shortly after a first heart attack to see if it can reduce heart damage when blood flow is restored. It is for patients having a specific type of heart attack (STEMI) and getting a procedure to open the blocked artery within 6 hours of symptoms starting.
Kingswood, New South WalesAges 40–75 - NCT07293923Recruiting
Magenta Elevate™ study for cardiogenic shock
This trial tests a new heart pump called the Magenta Elevate™ to help people whose heart suddenly stops pumping enough blood (cardiogenic shock). It aims to improve blood flow and reduce strain on the heart.
TbilisiAges 40–89 - NCT07276282RecruitingPhase 3
Ziltivekimab for heart attack patients with artery plaque
This trial tests a new drug called Ziltivekimab to see if it can reduce plaque buildup in the heart arteries after a heart attack. It may help prevent future heart problems by targeting inflammation.
BernAges 18 years+ - NCT07268391Recruiting
Advanced scans to understand heart healing after heart attack
This study uses advanced CT scans and blood tests to look at how the heart is damaged and recovers after a first heart attack. It may help doctors find better ways to treat heart attacks in the future.
MadridAges 18 years+ - NCT07208006Recruiting
Early cholesterol-lowering drug after heart attack
This trial tests whether giving a powerful cholesterol-lowering drug (PCSK9 inhibitor) very early after a heart attack can help prevent further heart problems. It is for people who have had a recent heart attack and have blockages in more than one heart artery.
Shanghai, Shanghai MunicipalityAges 18–100
Hear when a new AMI trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ami?
- Yes. Clin2 currently lists 45 recruiting ami studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ami trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ami trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.